| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA460: Adalimumab and dexamethasone for treating non-infectious uveitis |
|
Medicine details |
|
| Medicine name | adalimumab (Humira®) |
| Formulation | 40 mg/0.4 ml solution for injection |
| Reference number | 750 |
| Indication | Treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate |
| Company | AbbVie Ltd |
| BNF chapter | Eye |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 22/07/2016 |
| NICE guidance | TA460: Adalimumab and dexamethasone for treating non-infectious uveitis |